Stay updated with the latest developments, announcements, and stories from Biotis Pharmaceuticals Indonesia.
Lorem ipsum dolor, sit amet consectetur adipisicing elit. Animi quam, dolores error in nobis placeat voluptatum nisi voluptates facere eius omnis hic, facilis eveniet repudiandae nihil dolore illo nulla libero?
Our state-of-the-art manufacturing facility has been awarded international certification, marking a significant milestone in our commitment to global quality standards.
Biotis announces strategic partnerships with leading global health organizations to expand vaccine access across Southeast Asia.
Our R&D team launches an ambitious research program aimed at developing next-generation vaccines for emerging health challenges.
Investment in new manufacturing lines will increase our production capacity by 40%, ensuring stable supply of essential vaccines.
Reviewing a year of significant progress in our mission to strengthen Indonesia's health security and expand vaccine accessibility.
Our technology transfer initiatives continue to build sustainable vaccine production expertise within the country.